Search
for
Sort by
Research 151–180 of 915
- Polycystic ovary syndrome
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Genetics and Epigenetics of Polycystic Ovary Syndrome
- Severe Hyperandrogenism in A Premenopausal Woman With An Imaging-Negative Leydig Cell Tumor
- Hair loss in women
- Risk of Abnormal Pregnancy Completing Chemotherapy for Gestational Trophoblastic Tumor
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Ovarian hormones and adrenal androgens during a woman's life span
- Targets to treat androgen excess in polycystic ovary syndrome
- Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Androgenic effects of oral contraceptives: Implications for patient compliance
- Genetic basis of polycystic ovary syndrome
- Hirsutism in the Adolescent Female
- Hyperandrogenism in Women: Polycystic Ovary Syndrome
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Prevalence of Non-Scarring Alopecia among Female Patients Complaining from Hirsutism
- Female Antiandrogens
- Androgenic disorders
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic